DEFINITIVE CONTRACT
Active75F40126C00084
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$732.7K
obligated · signed 2 months ago
SCALABLE MONITORING PROCEDURES FOR GENERATIVE AI-BASED MEDICAL DEVICES
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2028
with all options
Loading status
Estimated start: Sep 29, 2027
REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE
Contract 75F40126C00084
UEI
KMH5K9V7S518
Parent Company
REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE
Capabilities & Certifications
Headquarters Location
Congressional District: 11
Current Obligation
$732,673
Base + Exercised Options
$732,673
Total Ceiling Value
$1,411,508
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
ADMINISTRATION OF PUBLIC HEALTH PROGRAMS
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.